Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose hCG for Oocyte Maturity in Poor Responders
NCT01509833Phase 3Completed
- Sponsor
- Royan Institute
- Start
- Oct 2009
- Primary completion
- Mar 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of human chorionic gonadotropin in infertility, sponsored by Royan Institute. Started Oct 2009; status: completed.
02
Drugs
human chorionic gonadotropin
03
Conditions
infertility
Beyond the preview
Go deeper on NCT01509833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01509833.